Xiao Huo

Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer

Juan Xu, Chuanxing Li, Jun-Ying Lv et al. · Molecular Cancer Therapeutics · 2011 · 233 citations

Medicine, Bioinformatics, Oncology +17

NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells

Ya Zhou, Yuanyuan Zhu, Xiaoyan Fan et al. · Oncotarget · 2017 · 66 citations · Full text

Medicine, Cell Biology, Oncology +17

Sertoli cell-mediated differentiation of male germ cell-like cells from human umbilical cord Wharton’s jelly-derived mesenchymal stem cells in an in vitro co-culture system

Lichun Xie, Li‐Min Lin, Qiuliu Tang et al. · European journal of medical research · 2015 · 54 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +10

EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer

Jiaqi Huang, Qianqian Yin, Yuqing Wang et al. · Advanced Science · 2024 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor

Tengrui Zhang, Zhengyang Guo, Xiao Huo et al. · EBioMedicine · 2022 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17